Crossject Stock OTC Markets
Stocks
CRJTF
FR0011716265
Medical Equipment, Supplies & Distribution
OTC Markets Traded
| Market Cap | 103M 118M 95.1M 89.02M 167M 11.11B 168M 1.13B 437M 5.47B 442M 433M 18.99B | P/E 2026 * |
4.6x | P/E 2027 * | 3.63x |
|---|---|---|---|---|---|
| Enterprise Value | 84.78M 97.24M 78.52M 73.51M 138M 9.18B 139M 932M 361M 4.52B 365M 357M 15.68B | EV / Sales 2026 * |
1.39x | EV / Sales 2027 * | 1.32x |
| Free-Float |
89.86% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -17.93% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 08/08/2001 | |
Lionel Seltz
DFI | Director of Finance/CFO | - | 25/03/2026 |
Tony C. Tipton
PRN | Corporate Officer/Principal | - | 20/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Teper
BRD | Director/Board Member | 66 | 07/06/2023 |
Eric Nemeth
BRD | Director/Board Member | 67 | - |
Philippe Monnot
CHM | Chairman | 67 | 26/06/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -17.93% | -.--% | - | - | 118M | |
| -5.03% | -6.34% | -20.24% | -70.56% | 84.2M | |
| -8.00% | -12.43% | +47.83% | +3.99% | 75.42M | |
| Average | -10.32% | -11.11% | +13.80% | -33.28% | 79.81M | |
| Weighted average by Cap. | -11.31% | -11.04% | +11.92% | -35.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 60.8M 69.73M 56.31M 52.71M 98.86M 6.58B 99.46M 668M 259M 3.24B 262M 256M 11.25B | 42.3M 48.51M 39.18M 36.67M 68.78M 4.58B 69.2M 465M 180M 2.25B 182M 178M 7.82B |
| Net income | 28.3M 32.46M 26.21M 24.54M 46.02M 3.06B 46.29M 311M 121M 1.51B 122M 119M 5.23B | 7.75M 8.89M 7.18M 6.72M 12.6M 839M 12.68M 85.15M 33M 413M 33.37M 32.65M 1.43B |
| Net Debt | -17.9M -20.53M -16.58M -15.52M -29.11M -1.94B -29.28M -197M -76.22M -953M -77.06M -75.41M -3.31B | -47M -53.91M -43.53M -40.75M -76.42M -5.09B -76.89M -516M -200M -2.5B -202M -198M -8.69B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
